Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$518M |
| 2 |
Procter & Gamble
PG
|
+$413M |
| 3 |
Merck
MRK
|
+$354M |
| 4 |
Amazon
AMZN
|
+$331M |
| 5 |
Hasbro
HAS
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$458M |
| 2 |
CELG
Celgene Corp
CELG
|
+$415M |
| 3 |
Mastercard
MA
|
+$305M |
| 4 |
Intuitive Surgical
ISRG
|
+$304M |
| 5 |
PayPal
PYPL
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 17.13% |
| 3 | Financials | 11.91% |
| 4 | Industrials | 10.9% |
| 5 | Consumer Discretionary | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
PNC Financial Services
PNC
$99.6B
| $60.2M | 0.03% |
377,067
-793,195
| -68% | -$119M |
|
527
TriNet
TNET
$2.94B
| $60.1M | 0.03% |
1,062,435
-233,198
| -18% | -$13M |
|
|
XLRN
528
DELISTED
Acceleron Pharma
XLRN
| $60.1M | 0.03% |
1,133,861
-211,544
| -16% | -$9.65M |
|
|
ONC
529
BeOne Medicines Ltd
ONC
$33.8B
| $59.9M | 0.03% |
361,389
-161,175
| -31% | -$26.8M |
|
|
ANSS
530
DELISTED
Ansys
ANSS
| $59.6M | 0.03% |
231,715
-123,491
| -35% | -$29.2M |
|
531
Live Nation Entertainment
LYV
$41.7B
| $59.5M | 0.03% |
778,146
-329,664
| -30% | -$22.3M |
|
|
LK
532
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $59.3M | 0.03% |
1,507,111
+214,993
| +17% | +$5.44M |
|
533
Delek US
DK
$3.95B
| $59.1M | 0.03% |
1,762,948
+198,431
| +13% | +$7.16M |
|
|
NTUS
534
DELISTED
Natus Medical Inc
NTUS
| $59M | 0.03% |
1,786,920
-1,160,452
| -39% | -$37.2M |
|
535
Vail Resorts
MTN
$5.28B
| $58.9M | 0.03% |
245,533
+181,663
| +284% | +$43M |
|
536
Xerox
XRX
$357M
| $58.4M | 0.03% |
1,583,486
+628,520
| +66% | +$22M |
|
537
MKS Inc
MKSI
$21.3B
| $58.2M | 0.03% |
528,891
-216,735
| -29% | -$22.7M |
|
538
Korn Ferry
KFY
$4.13B
| $57.7M | 0.03% |
1,360,862
+284,546
| +26% | +$11M |
|
539
RBC Bearings
RBC
$18.5B
| $57.5M | 0.03% |
363,169
-4,080
| -1% | -$660K |
|
540
Royal Caribbean
RCL
$81.8B
| $57.5M | 0.03% |
430,416
+243,292
| +130% | +$28.4M |
|
541
Fox Factory Holding Corp
FOXF
$779M
| $57.3M | 0.03% |
823,775
+61,832
| +8% | +$3.99M |
|
|
CNH
542
CNH Industrial
CNH
$13.7B
| $57.3M | 0.03% |
5,984,339
-3,614,613
| -38% | -$34M |
|
|
CARO
543
DELISTED
Carolina Financial Corp.
CARO
| $57.3M | 0.03% |
1,324,525
-96,733
| -7% | -$3.81M |
|
|
BNY
544
Bank of New York Mellon
BNY
$107B
| $56.9M | 0.03% |
1,131,406
+498,789
| +79% | +$23.8M |
|
545
Regions Financial
RF
$26.2B
| $56.7M | 0.03% |
3,304,212
-1,213,277
| -27% | -$20M |
|
|
PXD
546
DELISTED
Pioneer Natural Resource Co.
PXD
| $56.6M | 0.03% |
373,798
+250,021
| +202% | +$33.3M |
|
547
Ambarella
AMBA
$2.99B
| $56.5M | 0.03% |
933,242
+204,353
| +28% | +$11.3M |
|
548
Ecolab
ECL
$76.4B
| $56.4M | 0.03% |
292,487
-156,045
| -35% | -$29.6M |
|
549
Omnicell
OMCL
$1.89B
| $56.4M | 0.03% |
690,335
-10,410
| -1% | -$799K |
|
550
Enterprise Products Partners
EPD
$82.5B
| $56.1M | 0.03% |
1,992,199
-145,253
| -7% | -$3.94M |
|
Similar funds
Janus Henderson Group's Q4 2019 Portfolio in Review
As of Q4 2019, Janus Henderson Group held 1,494 positions worth $195B, up 5.8% from $185B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Janus Henderson Group's Q4 2019 filing shows 96 new, 553 increased, 735 reduced and 82 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M. The largest sale was Walt Disney, an estimated $458M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q4 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 5,875,619 shares worth $213M.
- Janus Henderson Group added most to Meta Platforms (Facebook) in Q4 2019, an estimated $518M increase.
- Janus Henderson Group's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $458M.
- Janus Henderson Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Janus Henderson Group's ten largest holdings make up 18% of its $195B portfolio in Q4 2019.
- Janus Henderson Group opened 96 new positions and closed 82 in Q4 2019.
- Janus Henderson Group's portfolio value rose 5.8% quarter-over-quarter to $195B.
Based on Janus Henderson Group's 13F filing for Q4 2019, filed 18 Feb 2020.